Completed OBSERVATIONAL NCT01715428

Liraglutide and Cardio-Metabolic Risk Markers

Effects of Liraglutide on Cardio-Metabolic Risk Markers

Sponsor: University of Palermo

Updated 12 times since 2017 Last updated: Nov 20, 2017 Started: Jun 30, 2012 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Type-2 Diabetes, this trial is completed. The trial is conducted by University of Palermo and has accumulated 12 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

12 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 7 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Dec 2017 — Apr 2018 [monthly]

Completed NA

Status: Unknown Status → Completed · Phase: PHASE3 → NA
Aug 2017 — Dec 2017 [monthly]

Unknown Status PHASE3
Jul 2017 — Aug 2017 [monthly]

Unknown Status PHASE3

Status: Active Not Recruiting → Unknown Status
Jan 2017 — Jul 2017 [monthly]

Active Not Recruiting PHASE3

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Palermo

Data source: University of Palermo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Palermo, Italy